• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Nat Commun . Structural convergence and water-mediated substrate mimicry enable broad neuraminidase inhibition by human antibodies

tetano

Editor, Senior Moderator
Nat Commun


. 2025 Aug 1;16(1):7068.
doi: 10.1038/s41467-025-62339-z. Structural convergence and water-mediated substrate mimicry enable broad neuraminidase inhibition by human antibodies

Julia Lederhofer[SUP] #[/SUP][SUP] 1 [/SUP], Andrew J Borst[SUP] #[/SUP][SUP] 2 3 [/SUP], Lam Nguyen[SUP] 1 [/SUP], Rebecca A Gillespie[SUP] 1 [/SUP], Connor J Williams[SUP] 4 [/SUP], Emma L Walker[SUP] 4 [/SUP], Julie E Raab[SUP] 1 [/SUP], Christina Yap[SUP] 1 [/SUP], Daniel Ellis[SUP] 2 3 5 [/SUP], Adrian Creanga[SUP] 1 [/SUP], Hyon-Xhi Tan[SUP] 6 [/SUP], Thi H T Do[SUP] 6 [/SUP], Michelle Ravichandran[SUP] 1 [/SUP], Adrian B McDermott[SUP] 1 [/SUP], Valerie Le Sage[SUP] 4 [/SUP], Sarah F Andrews[SUP] 1 [/SUP], Barney S Graham[SUP] 1 [/SUP], Adam K Wheatley[SUP] 6 [/SUP], Douglas S Reed[SUP] 4 [/SUP], Neil P King[SUP] 7 8 [/SUP], Masaru Kanekiyo[SUP] 9 [/SUP]



Affiliations
Abstract

Influenza has been responsible for multiple global pandemics and seasonal epidemics and claimed millions of lives. The imminent threat of a panzootic outbreak of avian influenza H5N1 virus underscores the urgent need for pandemic preparedness and effective countermeasures, including monoclonal antibodies (mAbs). Here, we characterize human mAbs that target the highly conserved catalytic site of viral neuraminidase (NA), termed NCS mAbs, and the molecular basis of their broad specificity. Cross-reactive NA-specific B cells were isolated by using stabilized NA probes of non-circulating subtypes. We found that NCS mAbs recognized multiple NAs of influenza A as well as influenza B NAs and conferred prophylactic protections in mice against H1N1, H5N1, and influenza B viruses. Cryo-electron microscopy structures of two NCS mAbs revealed that they rely on structural mimicry of sialic acid, the substrate of NA, by coordinating not only amino acid side chains but also water molecules, enabling inhibition of NA activity across multiple influenza A and B viruses, including avian influenza clade 2.3.4.4b H5N1 viruses. Our results provide a molecular basis for the broad reactivity and inhibitory activity of NCS mAbs targeting the catalytic site of NA through substrate mimicry.


 
Back
Top